RAREGEN Trademark

Trademark Overview

On Friday, August 24, 2018, a trademark application was filed for RAREGEN with the United States Patent and Trademark Office. The USPTO has given the RAREGEN trademark a serial number of 88091617. The federal status of this trademark filing is REGISTERED as of Tuesday, August 13, 2019. This trademark is owned by RareGen, LLC. The RAREGEN trademark is filed in the Advertising, Business and Retail Services category with the following description:

Promoting and marketing the pharmaceuticals of others
raregen

General Information

Serial Number88091617
Word MarkRAREGEN
Filing DateFriday, August 24, 2018
Status700 - REGISTERED
Status DateTuesday, August 13, 2019
Registration Number5836188
Registration DateTuesday, August 13, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 22, 2019

Trademark Statements

Pseudo MarkRARE GEN
Goods and ServicesPromoting and marketing the pharmaceuticals of others

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, September 4, 2018
Primary Code035
First Use Anywhere DateWednesday, October 31, 2018
First Use In Commerce DateWednesday, October 31, 2018

Trademark Owner History

Party NameLIQUIDIA PAH, LLC.
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressMORRISVILLE,, NC 27560
Party NameRareGen, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressMorrisville, NC 22902
Party NameRareGen, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCharlottesville, VA 22902
Party NameRareGen, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCharlottesville, VA 22902

Trademark Events

Event DateEvent Description
Wednesday, January 2, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 28, 2018NEW APPLICATION ENTERED
Tuesday, September 4, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 10, 2018ASSIGNED TO EXAMINER
Thursday, December 13, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 5, 2019TEAS STATEMENT OF USE RECEIVED
Wednesday, June 5, 2019USE AMENDMENT FILED
Tuesday, January 22, 2019PUBLISHED FOR OPPOSITION
Tuesday, January 22, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 19, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 17, 2019STATEMENT OF USE PROCESSING COMPLETE
Friday, July 12, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 13, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, January 18, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 17, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 11, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, January 18, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 18, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, January 18, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 13, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, May 17, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, January 18, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, February 15, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Related Keywords

raregen others pharmaceuticals marketing promoting